Summary of Significant Accounting Policies (Details Narrative) - USD ($) |
3 Months Ended | ||
|---|---|---|---|
Apr. 30, 2020 |
Apr. 30, 2019 |
Jan. 31, 2020 |
|
| Accounting Policies [Abstract] | |||
| Capitalized assets | $ 0 | $ 0 | |
| Accounts receivable, net | 0 | $ 0 | |
| Cash equivalents | 0 | 0 | |
| Uncollected reserve | 0 | 0 | |
| Loss on contingencies | 0 | $ 0 | |
| FCID Limit, excess | $ 0 | $ 0 | |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation. No definition available.
|
| X | ||||||||||
- Definition The amount of loss pertaining to the specified contingency that was charged against earnings in the period, including the effects of revisions in previously reported estimates. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The fair value of capitalized costs of a research and development nature that were acquired during the period in a transaction other than a business combination. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|